Sionna Therapeutics Inc banner
S

Sionna Therapeutics Inc
NASDAQ:SION

Watchlist Manager
Sionna Therapeutics Inc
NASDAQ:SION
Watchlist
Price: 37.38 USD -7.68%
Market Cap: $1.7B

Intrinsic Value

The intrinsic value for Sionna Therapeutics Inc (SION) under the Base Case is 0.54 USD. Compared with the current market price of 37.38 USD, the stock appears Overvalued by 99%.

SION Intrinsic Value
0.54 USD
Overvaluation 99%
Intrinsic Value
Price $37.38
S
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $0.43
Get notified when the price drops into your buy zone
Current Price $37.38
Intrinsic Value $0.54
Margin of Safety 20% $0.43
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about SION?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SION valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sionna Therapeutics Inc.

Explain Valuation
Alternatives to SION

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Sionna Therapeutics Inc

Efficiency

Earnings Waterfall
Sionna Therapeutics Inc

Wall St
Price Targets

Dividends

Sionna Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

SION Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SION stock?

The intrinsic value for Sionna Therapeutics Inc (SION) under the Base Case is 0.54 USD.

Is SION stock undervalued or overvalued?

Compared with the current market price of 37.38 USD, the stock appears Overvalued by 99%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett